Generation of human colon organoids from healthy and inflammatory bowel disease mucosa.
Isabella DottiAida MayorgasAzucena SalasPublished in: PloS one (2022)
Ulcerative colitis and Crohn's disease are chronic inflammatory bowel diseases (IBD) of unknown cause characterized by a relapsing-remitting behavior. Growing evidence supports the idea that the epithelial barrier plays a central role in the pathogenesis of IBD as well as in its evolution over time, thus representing a potential target for novel therapeutic options. In the last decade, the introduction of 3D epithelial cultures from ex vivo-expanded intestinal adult stem cells (ASCs) has impacted our ability to study the function of the epithelium in several gastrointestinal disorders, including IBD. Here, we describe in detail a reproducible protocol to generate Matrigel-embedded epithelial organoids from ASCs of non-IBD and IBD donors using small colonic biopsies, including steps for its optimization. A slightly modified version of this protocol is also provided in case surgical samples are used. With this method, epithelial organoids can be expanded over several passages, thereby generating a large quantity of viable cells that can be used in multiple downstream analyses including genetic, transcriptional, proteomic and/or functional studies. In addition, 3D cultures generated using our protocol are suitable for the establishment of 2D cultures, which can model relevant cell-to-cell interactions that occur in IBD mucosa.
Keyphrases
- ulcerative colitis
- stem cells
- multiple sclerosis
- randomized controlled trial
- induced pluripotent stem cells
- cell therapy
- single cell
- endothelial cells
- gene expression
- induced apoptosis
- signaling pathway
- disease activity
- systemic lupus erythematosus
- ultrasound guided
- mesenchymal stem cells
- drug induced
- case control
- copy number
- kidney transplantation